| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378)
|
Tryfonidis, Konstantinos
|
|
2016
|
53 |
C |
p. 144-154
11 p.
|
artikel
|
| 2 |
Association of TIMP3 expression with vessel density, macrophage infiltration and prognosis in human malignant melanoma
|
Das, Asha M.
|
|
2016
|
53 |
C |
p. 135-143
9 p.
|
artikel
|
| 3 |
Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial
|
Cashin, P.H.
|
|
2016
|
53 |
C |
p. 155-162
8 p.
|
artikel
|
| 4 |
Drug-related pneumonitis during mammalian target of rapamycin inhibitor therapy in patients with neuroendocrine tumors: a radiographic pattern-based approach
|
Nishino, Mizuki
|
|
2016
|
53 |
C |
p. 163-170
8 p.
|
artikel
|
| 5 |
Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics
|
Lipton, A.
|
|
2016
|
53 |
C |
p. 75-83
9 p.
|
artikel
|
| 6 |
Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC–STBSG) recommendations for pathological examination and reporting
|
Wardelmann, E.
|
|
2016
|
53 |
C |
p. 84-95
12 p.
|
artikel
|
| 7 |
Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway
|
van Maldegem, Annemiek M.
|
|
2016
|
53 |
C |
p. 171-180
10 p.
|
artikel
|
| 8 |
Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1)
|
Park, Sook Ryun
|
|
2016
|
53 |
C |
p. 42-50
9 p.
|
artikel
|
| 9 |
Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer
|
Lambrechts, Sandrina
|
|
2016
|
53 |
C |
p. 51-64
14 p.
|
artikel
|
| 10 |
Is change in blood pressure a biomarker of pazopanib and sunitinib efficacy in advanced/metastatic renal cell carcinoma?
|
Goldstein, David
|
|
2016
|
53 |
C |
p. 96-104
9 p.
|
artikel
|
| 11 |
Melanoma burden by melanoma stage: Assessment through a disease transition model
|
Tromme, Isabelle
|
|
2016
|
53 |
C |
p. 33-41
9 p.
|
artikel
|
| 12 |
MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma
|
Mirzaei, Hamed
|
|
2016
|
53 |
C |
p. 25-32
8 p.
|
artikel
|
| 13 |
Observer variability in RECIST-based tumour burden measurements: a meta-analysis
|
Yoon, Soon Ho
|
|
2016
|
53 |
C |
p. 5-15
11 p.
|
artikel
|
| 14 |
Risk-adapted approach for fever and neutropenia in paediatric cancer patients – A national multicentre study
|
Miedema, Karin G.E.
|
|
2016
|
53 |
C |
p. 16-24
9 p.
|
artikel
|
| 15 |
Risk factors for keratinocyte skin cancer in patients diagnosed with melanoma, a large retrospective study
|
Espinosa, Pablo
|
|
2016
|
53 |
C |
p. 115-124
10 p.
|
artikel
|
| 16 |
Selection for surgery and survival of synchronous colorectal liver metastases; a nationwide study
|
Norén, A.
|
|
2016
|
53 |
C |
p. 105-114
10 p.
|
artikel
|
| 17 |
Survival of patients with advanced metastatic melanoma: The impact of novel therapies
|
Ugurel, Selma
|
|
2016
|
53 |
C |
p. 125-134
10 p.
|
artikel
|
| 18 |
The ‘death pace’ in the CO.17 trial
|
Formica, Vincenzo
|
|
2016
|
53 |
C |
p. 1-4
4 p.
|
artikel
|
| 19 |
Utility of the CPS+EG staging system in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with neoadjuvant chemotherapy
|
Marmé, Frederik
|
|
2016
|
53 |
C |
p. 65-74
10 p.
|
artikel
|
Tijdschrift beschrijving